Clinical guidance: coronavirus

Guidance and services

• National protocol for COVID-19 mRNA vaccine in 5-year-old children to adults
• National protocol for Comirnaty Omicron XBB 1.5 30micrograms/dose Covid-19 Vaccine
• National protocol for Comirnaty Omicron XBB 1.5 10micrograms/dose Covid-19 Vaccine (children aged 5 to 11 years)
• National protocol for Moderna (Spikevax) XBB.1.5 COVID-19 vaccine
• National clinical framework: a learning health and care system
• National Protocol for Comirnaty 30micrograms/dose COVID-19 mRNA vaccine
• National protocol for Comirnaty (Children 5-11 years) COVID-19 mRNA vaccine
• National protocol for COVID-19 AstraZeneca (Vaxzevria) vaccine
• National Protocol for COVID-19 Moderna (Spikevax) vaccine
• National Protocol for COVID-19 Janssen vaccine
• Allied health professionals’ (AHP) role in rehabilitation during and after COVID-19
• COVID-19: non-emergency patient transport services (NEPTS) requirements and funding
• Coronavirus: ethical values and principles for healthcare delivery framework
• Coronavirus: National Institute for Health and Care Excellence (NICE)
• Public Health Wales' guidance for health and social care professionals
• National protocol for live attenuated influenza vaccine nasal spray suspension (LAIV)
• National protocol for inactivated influenza vaccine (IIV)

Policy and background Includes strategy, reports, projects and assessments.

• National protocol for Comirnaty Bivalent Original/Omicron BA.1 COVID-19 vaccine (Pfizer)
  Policy and strategy
• National Protocol for Spikevax® Bivalent Original/Omicron COVID-19 vaccine (Moderna)
  Policy and strategy
• Moderna COVID-19 vaccine: Directions and immunisation scheme specification for primary care
  Legislation
• Oxford/AstraZeneca COVID-19 vaccine: Directions and immunisation scheme specification for primary care
  Legislation
• All Wales Community Pathway For Long COVID
  Policy and strategy
• National protocol for Comirnaty Bivalent Original/Omicron BA.4.5 COVID-19 vaccine (Pfizer)
  Policy and strategy